MELBOURNE, Australia, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel treatments for recurrent and ...
MELBOURNE, Australia, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel treatments for recurrent and ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果